JP2024540439A5 - - Google Patents
Info
- Publication number
- JP2024540439A5 JP2024540439A5 JP2024527790A JP2024527790A JP2024540439A5 JP 2024540439 A5 JP2024540439 A5 JP 2024540439A5 JP 2024527790 A JP2024527790 A JP 2024527790A JP 2024527790 A JP2024527790 A JP 2024527790A JP 2024540439 A5 JP2024540439 A5 JP 2024540439A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- use according
- nitroxoline
- dose
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2116743.2A GB202116743D0 (en) | 2021-11-19 | 2021-11-19 | Treatment |
| GB2116743.2 | 2021-11-19 | ||
| PCT/GB2022/052933 WO2023089328A1 (en) | 2021-11-19 | 2022-11-18 | Nitroxoline for use in the treatment or prevention of a plexiform neurofibroma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024540439A JP2024540439A (ja) | 2024-10-31 |
| JP2024540439A5 true JP2024540439A5 (cg-RX-API-DMAC7.html) | 2025-11-17 |
Family
ID=79163954
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024527790A Pending JP2024540439A (ja) | 2021-11-19 | 2022-11-18 | 叢状神経線維腫の治療又は予防に使用するためのニトロキソリン |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250000852A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4433054B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024540439A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240108407A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118215479A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022392456A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3238805A1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB202116743D0 (cg-RX-API-DMAC7.html) |
| IL (1) | IL312885A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024006105A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023089328A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202218460D0 (en) * | 2022-12-08 | 2023-01-25 | Healx Ltd | Treatment |
| WO2026022492A1 (en) * | 2024-07-26 | 2026-01-29 | Healx Limited | Nitroxoline for use in the treatment and/or prevention of pain |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102239149B (zh) * | 2008-10-06 | 2015-05-13 | 约翰·霍普金斯大学 | 喹啉化合物作为血管新生、人类甲硫氨酰氨肽酶、以及sirt1的抑制剂,以及治疗病症的方法 |
| GB202108224D0 (en) * | 2021-06-09 | 2021-07-21 | Healx Ltd | Treatment |
-
2021
- 2021-11-19 GB GBGB2116743.2A patent/GB202116743D0/en not_active Ceased
-
2022
- 2022-11-18 CN CN202280074138.9A patent/CN118215479A/zh active Pending
- 2022-11-18 IL IL312885A patent/IL312885A/en unknown
- 2022-11-18 JP JP2024527790A patent/JP2024540439A/ja active Pending
- 2022-11-18 CA CA3238805A patent/CA3238805A1/en active Pending
- 2022-11-18 AU AU2022392456A patent/AU2022392456A1/en active Pending
- 2022-11-18 US US18/710,477 patent/US20250000852A1/en active Pending
- 2022-11-18 EP EP22812750.2A patent/EP4433054B1/en active Active
- 2022-11-18 WO PCT/GB2022/052933 patent/WO2023089328A1/en not_active Ceased
- 2022-11-18 KR KR1020247016458A patent/KR20240108407A/ko active Pending
- 2022-11-18 MX MX2024006105A patent/MX2024006105A/es unknown